The 3D Printing Filament Market was valued at USD 968 million in 2021 and is anticipated to exhibit a CAGR of 31.10% over the forecast period from 2021 to 2030.
Key Market Strategies of the Industry Participants
• June 2020: To enhance quick market-driven product development solutions, Koninklijke DSM N.V. (Netherland) has agreed to take over certain portions of Clariant AG's (Switzerland) 3D printing business portfolio. DSM purchased Clariant's 3D printing materials business, allowing it to deliver quick product development cycles for high-performance filaments and pellets based on application requirements. DSM's engineering grade filament, pellet, and powder portfolio will be strengthened as a result of the approach.
• April 2020: Stratasys Ltd. and Origin (Israel) have formed a strategic relationship to deliver 3D printed nasopharyngeal swabs to the healthcare industry. The business will sell and promote Origin 3D printed nasopharyngeal swabs to healthcare practitioners and testing centers in United States as part of this collaboration. This collaboration is intended to help the firm strengthen its position in the healthcare industry and extend its commercial applications.
• February 2020: Sanmina Corporation (U.S.) and 3D Systems Corporation (U.S.) have renewed their partnership for the manufacturing of specific plastic 3D printing platforms. For the production of the Figure 4 platform, the business already has an ongoing cooperation with Sanmina. With this new contract, the firm will be able to focus even more on its core capabilities of plastics materials and application development.
Major Companies: In this report, the major companies studied are Koninklijke DSM N.V (Netherland), Materialise NV (Belgium), Evonik Industries AG (Germany), Arkema SA (France), Saudi Basic Industries (Saudi Arabia), Corporation (SABIC) (Saudia Arabia), DuPont de Nemours, Inc. (U.S.), BASF 3D Printing Solutions GmbH (Germany), HP Inc. (U.S.), EOS GmbH – Electro Optical Systems (